However, bergamottin, a furanocoumarin, has also been shown in LC cells to inhibit TGF-β-induced EMT, invasiveness and multiple oncogenic cascades, such as PI3K/Akt/mTOR, thus showing its strong antimetastatic potentiality [66]. The gene discussed is AKT1; the disease is laryngotracheoesophageal cleft.